Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients

NCT04944433 is registered in ClinicalTrials.gov with Hospital Italiano de Buenos Aires as lead sponsor.

NCT NCT04944433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04944433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients
Lead sponsor
Hospital Italiano de Buenos Aires
Phase
Observational
Overall status
Completed
Start date
April 9, 2021
Completion date
August 4, 2022
Enrollment
950 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019 vaccines, renal dialysis